摘要:
A new piperidine compound is pharmacologically effective for treatment of the arrythmia and is defined by the formula: in which R 1 is a lower alkyl or a tolyl, R 2 is hydrogen, hydroxyl, a lower alkoxy or a lower alkyl, R 3 is hydrogen, a lower alkyl, a lower alkenyl, a cycloalkyl or a cycloalkylalkyl, X is -CO-, -CH 2 - or -CHOH-, g is an integer of 1 to 3, h is an integer of 1 to 3, Y is hydrogen, a lower alkyl, a lower alkenyl, cyano, -CH 2 COOR, R being hydrogen or a lower alkyl, a cycloalkyl, a cycloalkylalkyl, 1 being 1 or 2, -A-B, A being -(CH 2 )n-, n being an integer of 1 to 5, a straight-chain alkylene group having 1 to 5 carbon atoms which is a divalent group derived from a straight-chain alkane having lower alkyl, phenyl or hydroxyl. group(s) bonded directly to one or more carbon atoms constituting said alkane by removing a hydrogen atom bonded to each of the carbon atoms placed at both ends thereof, a straight-chain alkylene group having 1 to 5 carbon atoms which is a divalent group derived from a straight-chain alkene having a double bond formed between carbon atoms adjacent to each other by removing a hydrogen atom bonded to each of the carbon atoms placed at both ends thereof, k being an integer of 2 to 5, - (CH 2 )p-CO-, p being an integer of 1 to 4, B being cyano, - NR 4 R 5 , a heterocyclic ring or a condensed aromatic ring. A pharmaceutical composition containing said compounds as active ingredient, and the use of said compound in the preparation of a medicament for the treatment of arrhythmia are also disclosed.
摘要:
A novel propenoic acid derivative which exhibits adenosine A1 antagonism is defined by the general formula (I):
(wherein A represents an aromatic ring; R¹ represents aryl or the like; R², R³ and R⁴ each represent hydrogen, lower alkyl or the like; and R⁷ and R⁸ each represent lower alkyl or the like) or a pharmacologically acceptable salt thereof.
摘要翻译:表现出腺苷A1拮抗作用的新型丙烯酸衍生物由通式(I)定义:(其中A表示芳环; R 1表示芳基等; R 2,R 3, 和R 4各自表示氢,低级烷基等; R 7和R 8各自表示低级烷基等,或其药理学上可接受的盐。
摘要:
A new piperidine compound is pharmacologically effective for treatment of the arrythmia and is defined by the formula: in which R 1 is a lower alkyl or a tolyl, R 2 is hydrogen, hydroxyl, a lower alkoxy or a lower alkyl, R 3 is hydrogen, a lower alkyl, a lower alkenyl, a cycloalkyl or a cycloalkylalkyl, X is -CO-, -CH 2 - or -CHOH-, g is an integer of 1 to 3, h is an integer of 1 to 3, Y is hydrogen, a lower alkyl, a lower alkenyl, cyano, -CH 2 COOR, R being hydrogen or a lower alkyl, a cycloalkyl, a cycloalkylalkyl, 1 being 1 or 2, -A-B, A being -(CH 2 )n-, n being an integer of 1 to 5,
a straight-chain alkylene group having 1 to 5 carbon atoms which is a divalent group derived from a straight-chain alkane having lower alkyl, phenyl or hydroxyl. group(s) bonded directly to one or more carbon atoms constituting said alkane by removing a hydrogen atom bonded to each of the carbon atoms placed at both ends thereof, a straight-chain alkylene group having 1 to 5 carbon atoms which is a divalent group derived from a straight-chain alkene having a double bond formed between carbon atoms adjacent to each other by removing a hydrogen atom bonded to each of the carbon atoms placed at both ends thereof, k being an integer of 2 to 5, - (CH 2 )p-CO-, p being an integer of 1 to 4, B being cyano, - NR 4 R 5 , a heterocyclic ring or a condensed aromatic ring. A pharmaceutical composition containing said compounds as active ingredient, and the use of said compound in the preparation of a medicament for the treatment of arrhythmia are also disclosed.
摘要:
Piperidine compounds of general formula (XX) are provided which are useful as medicaments for the treatment or prophylaxis of arrhythmia. in which R¹ is a lower alkyl and W is: wherein X is -S-, -SO- or -SO₂-; R² is hydrogen or -(CH₂) n -Y; n is an integer of 1 to 5; Y is an aryl, pyridyl or a substituted pyridyl group; X′ is -CO- or -CH(OH)-; p is an integer of 1 to 4; R¹² is hydrogen or a lower alkyl group; Y′ is -(CH₂) m -A; m is 1 or 2; A is an aryl, a substituted aryl, pyridyl or a substituted pyridyl group; R¹² and Y may form a 5- or 6-membered ring or a 5- or 6-membered ring having one or more substituents; and R²² is hydrogen, a halogen, a lower alkyl, a lower alkoxy or hydroxy.